Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-3-8
pubmed:abstractText
Over-expression of the oncogene c-Myc has been implicated in the development and progression of human prostate carcinoma. However, previous assessments of c-Myc expression have not revealed its potential for predicting prostate carcinoma progression. Caveolin-1 is associated with prostate carcinoma progression and is a downstream target gene of c-Myc. The observation that caveolin-1 can suppress c-Myc-induced apoptosis suggested the potential for cooperation between c-Myc and caveolin-1 in malignant progression. In this study, the authors evaluated the prognostic potential of combined c-Myc and caveolin-1 expression in human prostate carcinoma progression.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1186-94
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15712208-Adenocarcinoma, pubmed-meshheading:15712208-Age Distribution, pubmed-meshheading:15712208-Aged, pubmed-meshheading:15712208-Biopsy, Needle, pubmed-meshheading:15712208-Caveolin 1, pubmed-meshheading:15712208-Caveolins, pubmed-meshheading:15712208-Cohort Studies, pubmed-meshheading:15712208-Confidence Intervals, pubmed-meshheading:15712208-Disease Progression, pubmed-meshheading:15712208-Humans, pubmed-meshheading:15712208-Immunohistochemistry, pubmed-meshheading:15712208-Male, pubmed-meshheading:15712208-Middle Aged, pubmed-meshheading:15712208-Predictive Value of Tests, pubmed-meshheading:15712208-Probability, pubmed-meshheading:15712208-Prognosis, pubmed-meshheading:15712208-Proportional Hazards Models, pubmed-meshheading:15712208-Prostatectomy, pubmed-meshheading:15712208-Prostatic Neoplasms, pubmed-meshheading:15712208-Proto-Oncogene Proteins c-myc, pubmed-meshheading:15712208-Risk Assessment, pubmed-meshheading:15712208-Sensitivity and Specificity, pubmed-meshheading:15712208-Survival Analysis, pubmed-meshheading:15712208-Tissue Culture Techniques, pubmed-meshheading:15712208-Treatment Outcome, pubmed-meshheading:15712208-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
pubmed:affiliation
Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.